You are here
-
Biotin-LC-beta-Amyloid (1-40)
Description This biotinylated Aß(1-40) contains a 6-carbon long chain (LC) to provide more accesibility for avidin attachment. (Shipping Cost: €35.00) -
[Pyr3]-beta-Amyloid (3-42)
Description This is one of the predominant amyloid peptide structures deposited in human brain of Alzheimer’s disease and Down’s syndrome patients. N-terminally truncated pyroglutamate-modified beta-Amyloid forms such as Aß(3-42) and Aß (11- 42) have been described as major compounds in the senile plaques. Pyro-Glu modified beta-Amyloid forms are more resistant to degradation, show higher toxicity and have increased aggregation propensity compared to non-modified beta-Amyloid. (Shipping Cost: €35.00) -
Beta-Amyloid (5-42)
Description A variety of truncated and modified Aβ peptides have been described (for example, 1-28, 1-29, 1-45, 2-46, 3-44, 3-47, 2-42, 4-42, 5-42, 6-42, 7-45, 8-42) (Shipping Cost: €35.00) -
Beta-Amyloid (42-1)
Description This peptide corresponds to the CtoN inverted sequence of Beta-amyloid 1-42. (Shipping Cost: €35.00) -
Beta-Amyloid (1-40), FAM-labeled
Description Beta-Amyloid (1-40) together with beta-Amyloid (1-42) are two major C-terminal variants of the beta-Amyloid protein. These beta-Amyloid peptides undergo post-secretory aggregation and deposition in the Alzheimer’s disease brain. This is a fluorescent (FAM)-labeled ß-Amyloid (1-40), Abs/Em=494/521 nm. FAM is preferred over FITC because of its photo- and chemical stability. | 494/521 (Shipping Cost: €35.00) -
Beta-Amyloid (1-40)-Lys(Biotin)-NH2
Description Beta-Amyloid (1-40) together with beta-Amyloid (1-42) are two major C-terminal variants of the beta-Amyloid protein. These beta-Amyloid peptides undergo post-secretory aggregation and deposition in the Alzheimer’s disease brain. This peptide is biotinylated at the C-terminus. (Shipping Cost: €35.00) -
ADAMTS-13 FRET Substrate, FRETS-VWF73
Description FRETS-VWF73 is a very powerful Fluorescence-Quenching Substrate for the VWF cleaving protease ADAMTS-13. It is commonly used as a useful tool for the rapid measurement of ADAMTS-13 activity in plasma and is a predictive marker for various thrombotic diseases like TPP. Our new substrate FRETS-VWF73 can be easily used with a 96-well format in commercial plate readers. (Shipping Cost: €35.00) -
[Pyr11]-beta-Amyloid (11-42)
Description Aßs are generated by the proteolytic processing of the amyloid ß-precursor protein (APP). Subsequent cleavage by g-secretase gives rise to Aß (1-40/42) and Aß (11-40/42). Aß (11-40) and Aß (11-42) are major Aß cleavage products generated by BACE. (Shipping Cost: €35.00) -
Beta-Amyloid (1-42)-Lys(Biotin)-NH2
Description Aß (1-42), a major component of amyloid plaques, accumulates in neurons of Alzheimer’s disease brains. Biochemical analysis of the amyloid peptides isolated from Alzheimer’s disease brain indicates that Aß (1-42) is the principal species associated with senile plaque amyloids, while Aß (1-40) is more abundant in cerebrovascular amyloid deposit. This peptide is biotinylated at the C-terminus. (Shipping Cost: €35.00) -
[Lys(Me2)9]-Histone H3 (1-21)-GGK(Biotin)
Description This peptide is Histone H3 amino acid residues 1 to 21 di-methylated at Lys-9 with a C-terminal GG linker followed by a biotinylated lysine. Provided at >95% peptide purity, this peptide was dissolved in distilled water at 1 mg/ml and re-lyophilized to powder form. (Shipping Cost: €35.00)